Life Sciences - Asia-Pacific Region
What the Team is Known For
King & Wood Mallesons acts on a broad range of matters in the life sciences space in China and Australia, including IP, regulatory work, financing and dispute resolution. The firm is particularly well versed in anti-bribery investigations in the biopharma and medical devices sectors. It is also able to draw on the resources of a noted corporate practice for support on financing, restructuring, IPO and M&A transactions in this practice area. The firm maintains a large network of offices across the region, including in Hong Kong, Japan and Singapore.
Strengths
"KWM has outstanding knowledge of the university sector and its intersection with government requirements for commercial and other agreements."
Work Highlights
King & Wood Mallesons acted for Gensco Pharma in relation to the supply of Australian infant formula products in North America to meet significant shortages of infant formula that have been caused by wide-scale recalls by the US Food and Drug Administration due to alleged bacterial contamination.
Notable practitioners
Matthew Swinn is a key contact in Australia and Beijing-based Zhu Nongfan is the main contact in China.
